These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 9829494)

  • 1. Acute effects of recombinant human erythropoietin on plasma levels of proendothelin-1 and endothelin-1 in haemodialysis patients.
    Kang DH; Yoon KI; Han DS
    Nephrol Dial Transplant; 1998 Nov; 13(11):2877-83. PubMed ID: 9829494
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intravenous erythropoietin (rHuEPO) administration increases plasma endothelin and blood pressure in hemodialysis patients.
    Carlini R; Obialo CI; Rothstein M
    Am J Hypertens; 1993 Feb; 6(2):103-7. PubMed ID: 8471228
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased endothelin: nitric oxide ratio is associated with erythropoietin-induced hypertension in hemodialysis patients.
    Shimada N; Saka S; Sekizuka K; Tanaka A; Takahashi Y; Nakamura T; Ebihara I; Koide H
    Ren Fail; 2003 Jul; 25(4):569-78. PubMed ID: 12911161
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of recombinant human erythropoietin therapy on plasma endothelin-1 levels during hemodialysis.
    Stefanidis I; Mertens PR; Wurth P; Bach R; Makropoulos W; Mann H; Heintz B
    Int J Artif Organs; 2001 Jun; 24(6):367-73. PubMed ID: 11482502
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of endothelin-converting enzyme in the systemic hemodynamics and regional circulatory effects of proendothelin-1 (1-38) and diaspirin cross-linked hemoglobin in rats.
    Gulati A; Singh R; Chung SM; Sen AP
    J Lab Clin Med; 1995 Dec; 126(6):559-70. PubMed ID: 7490515
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of subcutaneous and intraperitoneal administration of recombinant human erythropoietin on blood pressure and vasoactive hormones in patients on continuous ambulatory peritoneal dialysis.
    Lai KN; Lui SF; Leung JC; Law E; Nicholls MG
    Nephron; 1991; 57(4):394-400. PubMed ID: 1828543
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma endothelin in haemodialysis patients treated with recombinant human erythropoietin.
    Brunet P; Lorec AM; Leonetti F; Roubicek C; Jaber K; Roux F; Berland Y
    Nephrol Dial Transplant; 1994; 9(6):650-4. PubMed ID: 7970091
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Erythropoietin enhances vascular responsiveness to norepinephrine in renal failure.
    Hand MF; Haynes WG; Johnstone HA; Anderton JL; Webb DJ
    Kidney Int; 1995 Sep; 48(3):806-13. PubMed ID: 7474668
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recombinant human erythropoietin (rHuEPO) increases endothelin-1 release by endothelial cells.
    Carlini RG; Dusso AS; Obialo CI; Alvarez UM; Rothstein M
    Kidney Int; 1993 May; 43(5):1010-4. PubMed ID: 8510379
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blood pressure response to erythropoietin injection in hemodialysis and predialysis patients.
    Miyashita K; Tojo A; Kimura K; Goto A; Omata M; Nishiyama K; Fujita T
    Hypertens Res; 2004 Feb; 27(2):79-84. PubMed ID: 15005270
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma endothelin and big endothelin concentrations and serum endothelin-converting enzyme activity following aneurysmal subarachnoid hemorrhage.
    Juvela S
    J Neurosurg; 2002 Dec; 97(6):1287-93. PubMed ID: 12507125
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma pro-endothelin-1 peptide concentrations rise in chronic kidney disease and following selective endothelin A receptor antagonism.
    Dhaun N; Yuzugulen J; Kimmitt RA; Wood EG; Chariyavilaskul P; MacIntyre IM; Goddard J; Webb DJ; Corder R
    J Am Heart Assoc; 2015 Mar; 4(3):e001624. PubMed ID: 25801761
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The haematopoietic effect of recombinant human erythropoietin in haemodialysis is independent of the mode of administration (i.v. or s.c.).
    De Schoenmakere G; Lameire N; Dhondt A; Van Loo A; Van der Goten J; Duym P; Vanholder R
    Nephrol Dial Transplant; 1998 Jul; 13(7):1770-5. PubMed ID: 9681726
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proteolytic processing pattern of the endothelin-1 precursor in vivo.
    Struck J; Morgenthaler NG; Bergmann A
    Peptides; 2005 Dec; 26(12):2482-6. PubMed ID: 15978702
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of withdrawing ACE inhibitors on erythropoietin responsiveness and left ventricular hypertrophy in haemodialysis patients.
    Ertürk S; Nergizoğlu G; Ateş K; Duman N; Erbay B; Karatan O; Ertuğ AE
    Nephrol Dial Transplant; 1999 Aug; 14(8):1912-6. PubMed ID: 10462270
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hemodynamic effects of endothelin-1 and big endothelin-1 in chronic hemodialysis patients.
    Ottosson-Seeberger A; Ahlborg G; Hemsén A; Lundberg JM; Alvestrand A
    J Am Soc Nephrol; 1999 May; 10(5):1037-44. PubMed ID: 10232690
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipid and apolipoprotein patterns during erythropoietin therapy: roles of erythropoietin, route of administration, and diet.
    Allegra V; Martimbianco L; Vasile A
    Nephrol Dial Transplant; 1997 May; 12(5):924-32. PubMed ID: 9175044
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High blood soluble receptor p80 for tumour necrosis factor-alpha is associated with erythropoietin resistance in haemodialysis patients.
    Kato A; Odamaki M; Takita T; Furuhashi M; Maruyama Y; Hishida A
    Nephrol Dial Transplant; 2001 Sep; 16(9):1838-44. PubMed ID: 11522867
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endothelin-1 release by erythropoietin involves calcium signaling in endothelial cells.
    Carlini RG; Gupta A; Liapis H; Rothstein M
    J Cardiovasc Pharmacol; 1995 Dec; 26(6):889-92. PubMed ID: 8606524
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma and blood vessel endothelin-1 concentrations in hypertensive uremic rats treated with erythropoietin.
    Lebel M; Lacasse-M S; Larivière R; Kingma I; Grose JH
    Clin Exp Hypertens; 1998 Nov; 20(8):939-51. PubMed ID: 9817611
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.